Zeltia
 | |
| Company type | Sociedad Anónima |
|---|---|
| BMAD: ZEL | |
| ISIN | ES0184940817 |
| Industry | Pharmaceutical |
| Founded | Vigo, Galicia, Spain (August 3, 1939) |
| Defunct | 2015 |
| Headquarters | Madrid , Spain |
Area served | Worldwide |
Key people | José Fernández Sousa-Faro (Chairman) |
| Products | Pharmaceuticals |
| Revenue |  US$176 million (2009) |
| (US$46.3) million (2009) | |
| (US$40.3) million (2009) | |
| Total assets | US$302.9 million (2009) |
| Total equity |  US$59 million (2009) |
| Subsidiaries | PharmaMar, Genómica, Sylentis, Zelnova, Xylazel |
| Website | www |
| Footnotes / references [finan 1][history 1] | |
Zeltia is a former Spanish pharmaceutical company which operated through a variety of subsidiaries in the pharmaceutical and chemical industries. As of 2007, Zeltia's research activities in the pharmaceutical area had not resulted in a marketed product.[history 2] However, the company's majority shareholder and chairman are the same person, which has relieved the pressure which many CEOs have experienced to produce immediate returns.[history 3]
History[edit]
In 1993 Zeltia sells its subsidiary Cooper-Zeltia taking the name CZ Veterinaria, which years later would be renamed Zendal.[1]
The company was taken over by its subsidiary Pharma Mar in a reverse takeover, keeping the Zeltia's Group structure.
In 2018 PharmaMar sells Xylazel to the Dutch company AkzoNobel.[2][3]
In 2019 PharmaMar sells Zelnova, the group's last subsidiary in Galicia, to the Galician investment company Allentia Invest for 33 million euros.[4]
Subsidiaries[edit]
Direct subsidiaries as of 2009 were:[finan 2] Pharma Mar, S.A.U.; Genómica, S.A.U.; Zelnova, S.A; Protección de Maderas, S.A.U; Xylazel, S.A.; Noscira, S.A.; Sylentis, S.A.
Indirect subsidiaries which are direct subsidiaries of Pharma Mar as of 2009 were:[finan 2] Pharma Mar US; Pharma Mar AG; PharmaMar S.A.R.L.; Pharma Mar GmbH; Pharma Mar Ltd.
A single indirect subsidiary is a direct subsidiary of Zelnova, that being Copyr, S.p.A.[finan 2]
References[edit]
- ^ "El pueblo que levantó una industria". La Voz de Galicia. August 31, 2015.
- ^ "Pharma Mar vende su química gallega Xylazel por 21,8 millones » Galicia" (in Spanish). Retrieved July 25, 2022.
- ^ Construcción, Alimarket. "Akzo Nobel compra la fabricante gallega Xylazel - Noticias de Construcción en Alimarket, información económica sectorial". Alimarket.es (in Spanish). Retrieved July 25, 2022.
- ^ Ropero, Javier García (August 24, 2020). "Zelnova buscará compras y crecer en el exterior para facturar 100 millones en 2024". Cinco Días (in Spanish). Retrieved July 25, 2022.
Financial[edit]
- ^ "Zeltia, S.A." (database record). Austin, Texas, United States: Hoover's. Companies. Retrieved May 7, 2011.
- ^ a b c "Consolidated Financial Statements as of 31 December 2009". Zeltia. April 16, 2010. Retrieved May 7, 2011.
History[edit]
- ^ Bueno, María José Sánchez (2008), El proceso innovador y tecnológico: estrategias y apoyo público (Google Books) (in Spanish), Netbiblo, p. 175, ISBN 978-84-9745-240-3, OCLC 434255490, retrieved May 7, 2011
- ^ Clark, Todd D. (2007), "Spain", PharmaHandbook: a guide to the international pharmaceutical industry (Google Books) (5 ed.), New Orleans, Louisiana, United States: Value of Insight Consulting, p. 381, ISBN 978-0-9795443-0-9, OCLC 254331162, retrieved May 7, 2011
- ^ Jericó, Pilar (2009), "The Price of Fear", No Fear: In Business and In Life (Google Books), Basingstoke, United Kingdom: Palgrave Macmillan, p. 66, ISBN 978-0-230-58038-1, OCLC 636422030, retrieved May 7, 2011
